Brought to you by 
J&J's venture arm joins backers in 23andMe's $31mm Series C
11 Jan 2011
Executive Summary
New investor Johnson & Johnson Development Corp. has joined current shareholders New Enterprise Associates and Google Ventures, plus five undisclosed backers in 23andMe Inc.'s (personalized genetics) $22.2mm Series C venture round. According to the Form D filing, the company could bring in another $7.8mm before closing the financing.
Deal Industry
- In Vitro Diagnostics
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J's venture arm joins backers in 23andMe's $31mm Series C
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice